Plus: Chip stocks rise after TSMC posts strong April revenue figures. Novavax shares nearly double after the drugmaker strikes a licensing deal with French healthcare company Sanofi. J.R. Whalen reports.\n\n\n\nSign up for the WSJ's free What's News newsletter.\n\nLearn more about your ad choices. Visit megaphone.fm/adchoices